エーザイの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/01/17 | 6,219 | 6,266 | 6,144 | 6,155 | -43 | -0.7% | 623,600 |
2022/01/14 | 6,146 | 6,236 | 6,130 | 6,198 | -2 | ±0% | 1,310,700 |
2022/01/13 | 6,311 | 6,347 | 6,195 | 6,200 | -178 | -2.8% | 1,878,500 |
2022/01/12 | 6,348 | 6,408 | 6,220 | 6,378 | -170 | -2.6% | 2,115,300 |
2022/01/11 | 6,551 | 6,606 | 6,473 | 6,548 | +51 | +0.8% | 1,127,300 |
2022/01/07 | 6,565 | 6,598 | 6,443 | 6,497 | -90 | -1.4% | 1,011,000 |
2022/01/06 | 6,565 | 6,672 | 6,565 | 6,587 | +5 | +0.1% | 812,100 |
2022/01/05 | 6,550 | 6,600 | 6,516 | 6,582 | -34 | -0.5% | 1,202,900 |
2022/01/04 | 6,590 | 6,630 | 6,525 | 6,616 | +85 | +1.3% | 858,300 |
2021/12/30 | 6,577 | 6,609 | 6,507 | 6,531 | -45 | -0.7% | 1,160,700 |
2021/12/29 | 6,594 | 6,666 | 6,532 | 6,576 | -68 | -1% | 961,600 |
2021/12/28 | 6,579 | 6,688 | 6,566 | 6,644 | -22 | -0.3% | 1,157,100 |
2021/12/27 | 6,646 | 6,747 | 6,595 | 6,666 | +97 | +1.5% | 1,252,700 |
2021/12/24 | 6,473 | 6,613 | 6,430 | 6,569 | +92 | +1.4% | 2,230,000 |
2021/12/23 | 6,572 | 6,606 | 6,460 | 6,477 | -645 | -9.1% | 4,608,500 |
2021/12/22 | 7,037 | 7,181 | 7,031 | 7,122 | +85 | +1.2% | 977,700 |
2021/12/21 | 6,995 | 7,037 | 6,932 | 7,037 | +161 | +2.3% | 848,500 |
2021/12/20 | 6,860 | 6,966 | 6,826 | 6,876 | -98 | -1.4% | 978,900 |
2021/12/17 | 6,974 | 7,050 | 6,925 | 6,974 | -150 | -2.1% | 972,200 |
2021/12/16 | 7,140 | 7,147 | 7,024 | 7,124 | +181 | +2.6% | 907,500 |
2021/12/15 | 6,868 | 7,043 | 6,853 | 6,943 | +188 | +2.8% | 1,197,400 |
2021/12/14 | 6,749 | 6,829 | 6,714 | 6,755 | -28 | -0.4% | 892,900 |
2021/12/13 | 6,789 | 6,823 | 6,745 | 6,783 | +69 | +1% | 776,500 |
2021/12/10 | 6,783 | 6,823 | 6,702 | 6,714 | -133 | -1.9% | 1,304,800 |
2021/12/09 | 6,918 | 6,925 | 6,843 | 6,847 | -79 | -1.1% | 774,600 |
2021/12/08 | 6,937 | 6,977 | 6,854 | 6,926 | +40 | +0.6% | 770,100 |
2021/12/07 | 6,899 | 6,925 | 6,792 | 6,886 | +34 | +0.5% | 1,131,600 |
2021/12/06 | 6,898 | 6,926 | 6,822 | 6,852 | -93 | -1.3% | 660,700 |
2021/12/03 | 6,800 | 6,945 | 6,762 | 6,945 | +85 | +1.2% | 1,134,600 |
2021/12/02 | 6,785 | 6,947 | 6,785 | 6,860 | +80 | +1.2% | 1,155,400 |
2021/12/01 | 6,838 | 6,914 | 6,779 | 6,780 | -93 | -1.4% | 1,238,900 |
2021/11/30 | 7,051 | 7,098 | 6,865 | 6,873 | -172 | -2.4% | 2,912,800 |
2021/11/29 | 7,080 | 7,152 | 7,013 | 7,045 | -110 | -1.5% | 1,046,300 |
2021/11/26 | 7,160 | 7,176 | 7,053 | 7,155 | -39 | -0.5% | 947,800 |
2021/11/25 | 7,187 | 7,267 | 7,157 | 7,194 | +29 | +0.4% | 635,000 |
2021/11/24 | 7,308 | 7,360 | 7,118 | 7,165 | -161 | -2.2% | 928,400 |
2021/11/22 | 7,185 | 7,340 | 7,148 | 7,326 | +88 | +1.2% | 1,026,700 |
2021/11/19 | 7,247 | 7,266 | 7,076 | 7,238 | -135 | -1.8% | 2,399,000 |
2021/11/18 | 7,806 | 7,839 | 7,340 | 7,373 | -727 | -9% | 3,119,600 |
2021/11/17 | 8,230 | 8,257 | 8,040 | 8,100 | -163 | -2% | 703,200 |
2021/11/16 | 8,440 | 8,475 | 8,243 | 8,263 | -165 | -2% | 653,600 |
2021/11/15 | 8,345 | 8,447 | 8,287 | 8,428 | +119 | +1.4% | 650,500 |
2021/11/12 | 8,212 | 8,324 | 8,182 | 8,309 | +154 | +1.9% | 781,900 |
2021/11/11 | 8,156 | 8,254 | 8,122 | 8,155 | -13 | -0.2% | 517,800 |
2021/11/10 | 8,207 | 8,246 | 8,153 | 8,168 | -83 | -1% | 473,200 |
2021/11/09 | 8,309 | 8,395 | 8,239 | 8,251 | -64 | -0.8% | 560,300 |
2021/11/08 | 8,386 | 8,410 | 8,228 | 8,315 | -58 | -0.7% | 598,200 |
2021/11/05 | 8,455 | 8,483 | 8,307 | 8,373 | -76 | -0.9% | 647,300 |
2021/11/04 | 8,390 | 8,486 | 8,326 | 8,449 | +176 | +2.1% | 1,278,200 |
2021/11/02 | 8,226 | 8,366 | 8,188 | 8,273 | +89 | +1.1% | 870,100 |
701~
750
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「エーザイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
小野薬 | 174,700円 | -3.5% | -50.2% | 4.58% | 14.15倍 | 1.05倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム